Investment
Features
FeesSafety
Academy
More
Pluang+

Gold prices rise after softer U.S. inflation data lowers rate hike odds and weakens dollar and yields.

Market News
14 Jul 2026
FXEmpire
View Source
Bullish
Gold prices rise after softer U.S. inflation data lowers rate hike odds and weakens dollar and yields.

Gold prices rebounded from a two-week low to over $4,070 after U.S. June inflation data showed softer-than-expected increases, reducing the likelihood of a July Federal Reserve rate hike. This led to a drop in Treasury yields and the U.S. dollar, boosting gold's appeal as a safe haven. However, rising crude oil prices near $90 per barrel could pressure inflation again, potentially challenging gold's gains. Traders will watch if gold can sustain momentum and test resistance levels around $4,214 and the 50-day moving average near $4,333.

More News

Cardano launches node 11.1.1, starting rollout for Dijkstra hard fork with testing set for late 2026.

Cardano launches node 11.1.1, starting rollout for Dijkstra hard fork with testing set for late 2026.

Cardano released node version 11.1.1, marking the first step in the rollout of the Dijkstra hard fork, which introduces major updates like Plutus V4, Nested Transactions, and Linear Leios. This maintenance update removes legacy tracing and fixes memo...

Protocol Fundamentals
Bullish
4 hours ago
Chelsea's USDC jersey deal sparks fears of legal trouble for Hong Kong fans under local stablecoin laws

Chelsea's USDC jersey deal sparks fears of legal trouble for Hong Kong fans under local stablecoin laws

Chelsea FC's new jersey sponsorship with USDC has raised concerns among Hong Kong fans about potential legal risks under the city's strict stablecoin regulations. Hong Kong's Stablecoin Ordinance, effective since August 2025, penalizes unauthorized s...

Market News
Bearish
4 hours ago
Novartis' drug pelacarsen fails to reduce heart risks despite lowering harmful cholesterol Lp(a).

Novartis' drug pelacarsen fails to reduce heart risks despite lowering harmful cholesterol Lp(a).

Novartis announced that its drug pelacarsen, designed to lower the harmful cholesterol Lp(a), failed to significantly reduce cardiovascular events in a late-stage trial. This setback raises doubts about the effectiveness of targeting Lp(a) to prevent...

Market News
Bearish
4 hours ago
Mistral raises $3.5B to build AI infrastructure, aiming to rival OpenAI and Anthropic

Mistral raises $3.5B to build AI infrastructure, aiming to rival OpenAI and Anthropic

French AI startup Mistral raised 3 billion euros ($3.5 billion) led by Samsung and the EU-backed Scaleup Europe Fund, valuing the company at over 21 billion euros. The funding will help Mistral build its own data centers and expand computing capacity...

Market News
Bullish
4 hours ago
Palantir upgraded to 'Buy' on strong AI tech and 271% U.S. commercial growth.

Palantir upgraded to 'Buy' on strong AI tech and 271% U.S. commercial growth.

Palantir has been upgraded to a 'Buy' rating due to its unique AI architecture and meta-compute layer, which create a strong competitive advantage in enterprise and government AI markets. The company's value-based pricing benefits from AI compute cos...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App